Postoperative Nausea And Vomiting (PONV) Treatment Industrial and Market studies - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2016 - 2020

Albany, New York, Jan 11,2017

"Postoperative Nausea And Vomiting (PONV) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2016 - 2020" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.

Description-

Postoperative nausea and vomiting (PONV) is among the most common after surgery adverse events, which occur during the first 24 hours to 48 hours post surgery in patients. It has been observed that, on an average 20% to 30% of patients undergoing surgery suffer from vomiting and nausea postoperatively. The incidence of PONV depends on variety of factors, including type of surgery, gender and anesthetic drugs used. Generally, the consequences of PONV are minor, but the impact on medical resources and patient comfort can be significant.

Get Sample Report With TOC @ http://bit.ly/2j6gEz7

At present, the postoperative nausea and vomiting treatment market is expected to grow at a significant rate due to the high incidence rate of postoperative complications, which makes this industry a promising market venture.

– Some of the antiemetics commonly used for the management of PONV are:
Serotonin antagonists
Ondansetron
Granisetron
Dolasetron
Palonosetron
Steroids
Dexamethason
Cholinergic antagonists
Scopolamine
Dopamine antagonists
Butyrophenones
Benzamides
Phenothiazines
Antihistamines
Diphenhydramine
Dimenhydrinate

From the geographical perspective, North America and Europe are the largest markets for postoperative nausea and vomiting treatment market due to the elevated number of surgical procedures performed and high incidence rate of post surgery complications such as retching and dizziness. It is also observed that, after anesthesia cessation, PONV is the common cause of patient dissatisfaction. According to the International Anesthesia Research Society, more than 40 million undergo various surgeries annually in the U.S. and more than 100 million patients globally with almost 30% of the patients experiencing PONV. Studies also suggest that patients across North America and Europe often pay more than USD 100 to avoid postoperative complications. Thus, this huge base of patients suffering from postoperative nausea and vomiting is likely to boost the growth of the overall PONV treatment market. However, other regions such as South East Asia and Africa are some of the potential regions that are likely to grow in the near future.

The primary factors contributing to the growth of this market are rise in incidence rate of postoperative complications such as nausea, dizziness and vomiting along with increased numbers of surgical procedures performed among population. Moreover, introduction of promising drugs in this market is likely to boost the overall postoperative nausea and vomiting treatment market due to the high success and effectiveness rate of the potential molecules. Furthermore, increasing government support for developing novel therapies and personalized medicines along with high research and development initiatives on the development of cost-effective drugs are expected to fuel the growth of this market.

Additionally, advanced drug delivery technologies such as microneedle arrays and biodegradable particles along with increased focus on retaining superior quality of life are some of the factors that might contribute to the growth of this market. However, rise in overall healthcare expenditure, tedious regulatory approval and product availability are some of the market-restraining factors that might hinder the growth of the post operative nausea and vomiting treatment market in the near future.

Currently, the postoperative nausea and vomiting treatment market is a burgeoning and promising market venture due to the high incidence of post surgery complications such as vomiting and dizziness along increased number of surgical procedures. However, at present the market is highly fragmented owing to the involvement of many established as well as emerging players in this industry. Some of the key market players operating in this market are Acacia Pharma Ltd., Actavis plc, AstraZeneca plc and GlaxoSmithKline plc, amongst others.

– This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
North America 
Asia Pacific 
Europe
Rest of the World  

– This report provides comprehensive analysis of 
Market growth drivers 
Factors limiting market growth
Current market trends 
Market structure
Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

– Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth 
It provides a six-year forecast assessed on the basis of how the market is predicted to grow 
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
It provides distinctive graphics and exemplified SWOT analysis of major market segments

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Researchmoz Global Pvt. Ltd.
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074

This release was published on openPR.